CAS: 62498-67-3 - 1-(4-fluorophenyl)-1,3-dihydro-1-[3-(methylamino)propyl]isobenzofuran-5-carbonitrile
Fórmula:C19H19FN2O
InChI:InChI=1S/C19H19FN2O/c1-22-10-2-9-19(16-4-6-17(20)7-5-16)18-8-3-14(12-21)11-15(18)13-23-19/h3-8,11,22H,2,9-10,13H2,1H3
Clave InChI:InChIKey=PTJADDMMFYXMMG-UHFFFAOYSA-N
SMILES:N#CC1=CC=C2C(=C1)COC2(C3=CC=C(F)C=C3)CCCNC
- Sinónimos:
- (±)-Desmethylcitalopram
- (±)-N-Demethylcitalopram
- 1-(4-Fluorophenyl)-1,3-dihydro-1-[3-(methylamino)propyl]-5-isobenzofurancarbonitrile
- 1-(4-Fluorophenyl)-1-[3-(Methylamino)Propyl]-1,3-Dihydro-2-Benzofuran-5-Carbonitrile
- 5-Isobenzofurancarbonitrile, 1-(4-fluorophenyl)-1,3-dihydro-1-[3-(methylamino)propyl]-
- Demethylcitalopram
- Lu 11-109
- Monodesmethylcitalopram
- Norcitalopram
- Rac-Desmethylcitalopram
- Ver más sinónimos
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Citalopram EP Impurity D HBr (Citalopram USP Related Compound D HBr, N-Desmethyl Citalopram HBr) REF: 4Z-C-095CAS: | - - - | A consultar | Mar 10 Dic 24 | |
1-(4-Fluorophenyl)-1,3-Dihydro-1-[3-(Methylamino)Propyl]Isobenzofuran-5-Carbonitrile REF: 3D-FF101068CAS: 62498-67-3 | Min. 95% | A consultar | Vie 17 Ene 25 |
Citalopram EP Impurity D HBr (Citalopram USP Related Compound D HBr, N-Desmethyl Citalopram HBr)
Fórmula:
C19H19FN2O·HBr
Forma y color:
White To Off-White Solid
Peso molecular:
310.37 80.91
Ref: 4Z-C-095
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
1-(4-Fluorophenyl)-1,3-Dihydro-1-[3-(Methylamino)Propyl]Isobenzofuran-5-Carbonitrile
CAS:62498-67-3
1-(4-Fluorophenyl)-1,3-Dihydro-1-[3-(Methylamino)Propyl]Isobenzofuran-5-Carbonitrile is a chiral compound that is structurally related to citalopram. It has been shown …
Fórmula:
C19H19FN2O
Pureza:
Min. 95%
Peso molecular:
310.37 g/mol
Ref: 3D-FF101068
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 17 de Enero de 2025